secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2025-03-21T23:59:59+00:00
Accession:  0001628280-25-014209
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE posts record Q4 revenue $10.3M, FY rev $32.6M; guides 47-53% growth in FY2025
--------------------------------------------------------------------------------

- Q4 2024 revenue $10.3M (+47% YoY); full year $32.6M (+60% YoY), both all-time records.
- Gross margin improved to 77.9% (Q4) and 75.2% (FY); operating income $2.5M (Q4) and $5.4M (FY).
- Adjusted EBITDA $3.7M in Q4 (vs $0.7M) and $7.2M for FY (vs -$1.2M), positive cash flow from operations.
- Net loss $31.4M for FY driven by derivative liability fair value changes; capital structure simplified.
- Guidance: Q1 2025 rev $8.4-9.0M (+45-55%); FY2025 rev $48-50M (+47-53%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025014209/0001628280-25-014209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025014209/snwv-20250321.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-014209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer